MEREO BIOPHARMA GROUP PLC Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments
MEREO BIOPHARMA GROUP PLC (MREO) reported Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments of GBP 32.87 million for the 12-month period ending 2019-12-31, per its 20-F filed 2022-03-31.
Discontinued › Notes
ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments · last filed 2022-03-31
| Period end | Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments 6 month | Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments 12 month |
|---|---|---|
| 2019-12-31 | 32.87M GBP 20-F · filed 2022-03-31 | |
| 2019-06-30 | 12.46M GBP 6-K · filed 2020-09-29 | |
| 2017-12-31 | -2.50M GBP 20-F · filed 2020-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |